Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MUNIB S DAUDJEE

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1417141706
CMS profile
1143969
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,723.59

64 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,716.07 63
Education $7.52 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–64 of 64 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MUNIB S DAUDJEE

NPI 1417141706 · CMS profile ID 1143969

Allopathic & Osteopathic Physicians / Internal Medicine

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–64 of 64 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417141706?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MUNIB S DAUDJEE, NPI 1417141706, CMS profile ID 1143969. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–64 of 64 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417141706?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MUNIB S DAUDJEE, NPI 1417141706, CMS profile ID 1143969. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–64 of 64 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417141706?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MUNIB S DAUDJEE, NPI 1417141706, CMS profile ID 1143969, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–64 of 64 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1417141706?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

64 matching records · $1,723.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 64 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–64 of 64.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $22.6303/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729642 CMS
ABBVIE INC. $8.5703/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729638 CMS
Supernus Pharmaceuticals, Inc. $7.5203/21/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1244880767 CMS
ABBVIE INC. $7.2903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729636 CMS
ABBVIE INC. $12.7802/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729634 CMS
Phathom Pharmaceuticals, Inc. $110.7502/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219335484 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.5702/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231971314 CMS
Novo Nordisk Inc $7.7402/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188469647 CMS
ABBVIE INC. $8.0802/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729632 CMS
ABBVIE INC. $16.0601/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729630 CMS
ABBVIE INC. $30.4801/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729626 CMS
ABBVIE INC. $20.1601/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729628 CMS
ABBVIE INC. $8.0501/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201729624 CMS
Dexcom, Inc. $16.3601/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250510570 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $296.88 10
PY2020 $346.05 21
PY2021 $375.26 16
PY2022 $882.67 47
PY2023 $1,066.02 77
PY2024 $791.44 45
PY2025 $1,723.59 64

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Principal investigator $66,654.63 18

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $2,500.00 12/13/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681099101
Principal investigator 1 Novo Nordisk AS $500.00 12/03/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN2211-4232 No dispute reported 06/30/2026 692461633
Principal investigator 1 Novo Nordisk AS $16,580.40 12/03/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN2211-4232 No dispute reported 06/30/2026 692461635
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $2,396.81 08/19/2019 Non-covered Recipient Entity
Mercury Clinical Research Inc
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691589017
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $30.00 07/02/2019 Non-covered Recipient Entity
Mercury Clinical Research Inc
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691588629
Principal investigator 1 Novo Nordisk AS $500.00 05/23/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN9535-4270 No dispute reported 06/30/2026 692461627
Principal investigator 1 Novo Nordisk AS $1,000.00 05/23/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN9535-4270 No dispute reported 06/30/2026 692461629
Principal investigator 1 Novo Nordisk AS $433.82 05/23/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN9535-4270 No dispute reported 06/30/2026 692461631
Principal investigator 1 Genentech, Inc. $188.00 05/17/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681078533
Principal investigator 1 SANOFI US SERVICES INC. $2,792.00 05/13/2019 Non-covered Recipient Entity
Mercury Clinical Research Inc
A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers No dispute reported 06/30/2026 691609247
Principal investigator 1 Genentech, Inc. $1,210.00 04/02/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681096021
Principal investigator 1 Genentech, Inc. $1,879.00 03/28/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681094389
Principal investigator 1 SANOFI US SERVICES INC. $2,327.00 03/11/2019 Non-covered Recipient Entity
Mercury Clinical Research Inc
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691547527
Principal investigator 1 Novo Nordisk AS $1,312.00 02/26/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH
NN2211-4232 No dispute reported 06/30/2026 692461625
Principal investigator 1 Genentech, Inc. $8,770.00 02/25/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681091135
Principal investigator 1 Amarin Pharma Inc. $2,294.60 02/18/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio No dispute reported 06/30/2026 700952257
Principal investigator 1 SANOFI-AVENTIS U.S. LLC $13,441.00 01/28/2019 Non-covered Recipient Entity
Mercury Clinical Research Inc
A 26-week randomized, open-label, active-controlled, 2-treatment arm, parallel group multi-center study, comparing the efficacy and safety of Soliqua 100/33 versus Lantus in ethnically/racially divers No dispute reported 06/30/2026 691566855
Principal investigator 1 Genentech, Inc. $8,500.00 01/14/2019 Non-covered Recipient Entity
MERCURY CLINICAL RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS 1 12 YEARS No dispute reported 06/30/2026 681092033